The IPC Board seeks colleagues who hold a position in a professional specialty relevant to IPC’s mission. The individual either manages the care of people with psoriasis or performs research relevant to psoriasis and its multiple co-morbidities.
Councilor selection will be based on the individuals’ level of expertise based on the following guiding principles:
Complete the IPC Councilor application form describing your expertise and experience in psoriasis and/or its multiple co-morbidities. Provide the names of two IPC Councilors or Board Members who may support your application, each from a different country (If you do not know any of the Councilors or Board Members, leave this field blank; this does not necessarily disqualify you from membership).
Submit your current curriculum vitae (CV) to info@psoriasiscouncil.org
IPC Nomination Committee will review your application and CV, and if necessary additional information will be requested to support your application. If the nomination committee believes you have the experience and expertise to become an IPC Councilor, you will then need to supply the following information:
Your complete application will then be forwarded to the IPC Board of Directors for consideration at its next scheduled board meeting. For more information, please contact info@psoriasiscouncil.org
become one of Our Experts Councilor Application Apply Now
Latest news Dermavant Announces FDA Approval for VTAMA® (Tapinarof) CreamMay 26, 2022Dermavant announced the FDA approval for VTAMA® (tapinarof) cream, 1% for the Treatment of Plaque Psoriasis in Adults. This is the first topical novel chemical entity launched for psoriasis in the U.S. in 25 years. Bristol Myers Squibb (BMS) Announces New Two-Year Deucravacitinib DataMay 16, 2022Bristol Myers Squibb (BMS) announced new two-year data that reinforces the durable efficacy and consistent safety profile of Deucravacitinib when used to treat moderate to severe plaque psoriasis. Commentary: Vaccine Hesitancy and Access to Psoriasis Care in the COVID-19 PandemicMay 11, 2022IPC Councilor, Ulrich Mrowietz, MD, shares his expert opinion on Cook et al (Br J Dermatol 2022 (online first)) report on the interruption of psoriasis care during the COVID-19 pandemic and vaccine hesitancy in patients with psoriasis. New Corporate MemberMay 03, 2022IPC is pleased to welcome AnaptysBio as a Bronze Level Corporate Member! More News